The 80,000ft² will develop fracture fixation implants as well as instruments for hip procedures and spine fixation.

Greatbatch Medical president Mauricio Arellano said the $17m investment is the third project the company has deployed as part of an overall strategy to partner with orthopaedic device makers.

"We have made strategic investments with an intense focus on growing our global orthopaedics business through a sound commercial strategy, continuous investments in medical device innovations and streamlined operations and best in class execution," Arellano added.

Greatbatch Medical president and CEO Thomas Hook said, "This investment is a critical part of our growth strategy as we strive to achieve growth in our core business, growth through targeted acquisitions and growth through new, innovative medical devices."